Nuclear medicine theragnostics: walk before you run
Theragnostic nuclear medicine is a much discussed topic in nuclear medicine and is currently discussed and debated in clinical oncology with great interest and optimism. Radionuclide theragnostics generally pairs diagnostic biomarkers with radiolabelled therapeutic agents that share a specific target within the diseased cells or tissues. The clinical indications are expanding, with evolving evidence. Incorporating […]
Dr Gopinath Gnanasegaran, Dr Shaunak Navalkissoor
Royal Free London NHS Foundation Trust